TJWY Medical
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
TJWY Medical - overview
Established
2008
Location
Beijing, -, China
Primary Industry
Medical Devices & Equipment
About
Based in Beijing, China, and founded in 2008, TJWY Medical operates as a developer of neuro-interventional devices and in vitro diagnostic reagents, integrating R&D, production, sales, and service. It has a production base of more than 6,800 square meters, nearly 2,000 square meters of class 10,000 clean production workshop, and a 100-class ultra-clean table microbiology laboratory. The company has passed GMP and ISO13485 quality system certifications and owns more than 50 intellectual property rights, including more than 20 invention patents and over 20 trademarks. In January 2023, TJWY Medical completed a strategic investment.
TJWY Medical is mainly engaged in the research and development, production, sales, and service of neuro-interventional and biological rapid diagnostic reagents POCT and other medical devices. Its main products include intravascular catheters, embolization devices, implantation devices, stents, in vitro diagnostic reagents, clinical tests, and analysis instruments. The company's products can be used in the field of rapid quantitative colloidal gold testing for brain, heart, and kidney markers.
Current Investors
Shenzhen Capital Real Estate Fund, Infinity Group, Vivo Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Cardiology, Diagnostic Equipment
Website
www.tjwymedical.com
Verticals
Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.